JPS63502899A - リポソームおよびβ↓２‐レセプター活性物質の組成物 - Google Patents

リポソームおよびβ↓２‐レセプター活性物質の組成物

Info

Publication number
JPS63502899A
JPS63502899A JP50214287A JP50214287A JPS63502899A JP S63502899 A JPS63502899 A JP S63502899A JP 50214287 A JP50214287 A JP 50214287A JP 50214287 A JP50214287 A JP 50214287A JP S63502899 A JPS63502899 A JP S63502899A
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
liposomes
receptor active
terbutaline sulfate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50214287A
Other languages
English (en)
Japanese (ja)
Inventor
アクセルソン，ベンクト・インゲマル
ビイストリヨーム，ウツラ・カタリーナ
ダールベツク，カール・マグヌス・オロフ
ケツルストリヨーム，レイフ・アーネ
ニルソン，ペル‐グンナル
トロフアスト，ヤン・ヴイリアム
Original Assignee
アクチエボラゲツト・ドラコ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アクチエボラゲツト・ドラコ filed Critical アクチエボラゲツト・ドラコ
Publication of JPS63502899A publication Critical patent/JPS63502899A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
JP50214287A 1986-04-01 1987-03-23 リポソームおよびβ↓２‐レセプター活性物質の組成物 Pending JPS63502899A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8601457A SE8601457D0 (sv) 1986-04-01 1986-04-01 Compositions of liposomes and b?712-receptor active substances for inhalation
SE8601457-8 1986-04-01

Publications (1)

Publication Number Publication Date
JPS63502899A true JPS63502899A (ja) 1988-10-27

Family

ID=20364009

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50214287A Pending JPS63502899A (ja) 1986-04-01 1987-03-23 リポソームおよびβ↓２‐レセプター活性物質の組成物

Country Status (5)

Country Link
EP (1) EP0298984A1 (fr)
JP (1) JPS63502899A (fr)
AU (1) AU7207687A (fr)
SE (1) SE8601457D0 (fr)
WO (1) WO1987005803A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510830A (ja) * 1994-12-22 1998-10-20 アストラ・アクチエボラーグ 吸入用プロリポソーム粉末
JP2013532722A (ja) * 2010-08-05 2013-08-19 ピラマル エンタープライジーズ リミテッド 感染症治療用抗感染性分子の経肺薬物送達用微粒子製剤

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990014105A1 (fr) * 1989-05-15 1990-11-29 The Liposome Company, Inc. Accumulation de medicaments dans des liposomes au moyen d'un gradient protonique
DE3917617A1 (de) * 1989-05-31 1990-12-06 Boehringer Ingelheim Kg Mikronisierte bioabbaubare partikel, verfahren zur ihrer herstellung und ihre verwendung
FR2650181B1 (fr) * 1989-07-27 1993-12-03 Laboratoire Stallergenes Procede pour combiner un melange de substances heterogenes a des liposomes
EP0416925A3 (en) * 1989-09-07 1991-09-25 Glaxo Group Limited Use of 4-hydroxy-alpha 1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol or its salts in the treatment of allergy and inflammation
GB9111611D0 (en) * 1991-05-30 1991-07-24 Sandoz Ltd Liposomes
FR2690341A1 (fr) * 1992-04-24 1993-10-29 Patrinove Vecteurs nanoparticulaires contenant un musculotrope ou un neurotrope à effet déclenché par variation du potentiel des membranes des cellules ciblées par l'actif encapsulé.
US6344576B1 (en) 1997-08-18 2002-02-05 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Phospholipid-analogous compounds
GB9912639D0 (en) 1999-05-28 1999-07-28 Britannia Pharmaceuticals Ltd Improvements in and relating to treatment of respiratory conditions
DE10214983A1 (de) * 2002-04-04 2004-04-08 TransMIT Gesellschaft für Technologietransfer mbH Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
DE102009031274A1 (de) 2009-06-30 2011-01-13 Justus-Liebig-Universität Giessen Liposomen zur pulmonalen Applikation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CH621479A5 (fr) * 1977-08-05 1981-02-13 Battelle Memorial Institute
EP0152379A3 (fr) * 1984-02-15 1986-10-29 Ciba-Geigy Ag Procédé pour la préparation de compositions pharmaceutiques contenant des liposomes unilamellaires
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
GB8423436D0 (en) * 1984-09-17 1984-10-24 Riker Laboratories Inc Preparation of liposomes

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10510830A (ja) * 1994-12-22 1998-10-20 アストラ・アクチエボラーグ 吸入用プロリポソーム粉末
JP2013532722A (ja) * 2010-08-05 2013-08-19 ピラマル エンタープライジーズ リミテッド 感染症治療用抗感染性分子の経肺薬物送達用微粒子製剤

Also Published As

Publication number Publication date
WO1987005803A1 (fr) 1987-10-08
SE8601457D0 (sv) 1986-04-01
EP0298984A1 (fr) 1989-01-18
AU7207687A (en) 1987-10-20

Similar Documents

Publication Publication Date Title
RU2162689C2 (ru) Пролипосомные порошки для ингаляции
AU603139B2 (en) A new system for administration of liposomes to mammals
US20090047336A1 (en) novel formulation of dehydrated lipid vesicles for controlled release of active pharmaceutical ingredient via inhalation
JPH0534334B2 (fr)
CH680983A5 (fr)
JPS63502899A (ja) リポソームおよびβ↓２‐レセプター活性物質の組成物
JP2002510311A (ja) トコフェロールにより安定化された吸引用プロリポソーム粉末
JPH10512876A (ja) コルチコステロイドを含有するリポソーム
JPH01165523A (ja) ネドクロミルナトリウム組成物およびその調製方法
JPH06502427A (ja) 合成肺表面活性剤
JPH0776180B2 (ja) 吸入アレルゲンを含有するアレルギー治療用リポソーム
CN100467013C (zh) 一种包覆辛夷挥发油纳米脂质体滴鼻剂
BR112020026629A2 (pt) Composições farmacêuticas na forma liofilizada
KR100294834B1 (ko) 호흡기질환치료용제약조성물
JP3202704B2 (ja) 医療用のリポソームおよび薬物含有リポソームのエアゾールの小粒子
CN111432801A (zh) 缓释型曲普坦组合物及通过皮下或类似途径使用其的方法
JPH0380773B2 (fr)
MXPA97004406A (en) Proliposomas powders for inhalac
MXPA99011675A (en) Proliposome powders for inhalation stabilised by tocopherol
KR20070018065A (ko) 비염 치료를 위한 방법 및 조성물
CZ466799A3 (cs) Proliposomové prášky stabilizované tokoferolem pro inhalační účely